Tohru Ohnuma
0000-0003-1522-3832
86 papers found
Refreshing results…
Use of skin advanced glycation end product levels measured using a simple noninvasive method as a biological marker for the diagnosis of neuropsychiatric diseases
Young age and severity of motor function are risk factors for psychosis after subthalamic nucleus deep brain stimulation for Parkinson's disease
Skin advanced glycation end products as biomarkers of photosensitivity in schizophrenia
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect
Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia
High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia
High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia
Medium‐chain triglycerides given in the early stage of mild‐to‐moderate Alzheimer's disease enhance memory function
Estimated cognitive decline in patients with schizophrenia: A multicenter study
Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case–control study
Correction: Corrigendum: Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders
Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population
Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders
Association of copy number polymorphisms at the promoter and translated region of COMT with Japanese patients with schizophrenia
Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment
Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study
Associations of common copy number variants in glutathione S-transferase mu 1 and D-dopachrome tautomerase-like protein genes with risk of schizophrenia in a Japanese population
Erratum to: Genetic Association Between KIBRA Polymorphism and Alzheimer’s Disease with in a Japanese Population
Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia
Missing publications? Search for publications with a matching author name.